+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Targeted next-generation sequencing approach for molecular genetic diagnosis of hereditary colorectal cancer: Identification of a novel single nucleotide germline insertion in adenomatous polyposis coli gene causes familial adenomatous polyposis



Targeted next-generation sequencing approach for molecular genetic diagnosis of hereditary colorectal cancer: Identification of a novel single nucleotide germline insertion in adenomatous polyposis coli gene causes familial adenomatous polyposis



Molecular Genetics and Genomic Medicine 7(1): E00505



Familial adenomatous polyposis (FAP) is an autosomal dominantly inherited disease which primarily manifested with developing adenomas or polyps in colon or rectum. It is caused by the germline mutations in adenomatous polyposis coli (APC) gene. Patients with FAP are usually manifested with "hundreds or even thousands" adenomas or polyps in colon or rectum. However, without proper clinical diagnosis and timely surgical interventions, colorectal adenomas, or polyps gradually increase in size and in numbers which finally leads to colorectal cancer (CRC) at the mean age of 36 years of the patient. In this study, we identified a family with FAP. In this family, FAP has been diagnosed clinically based on symptoms, medical test reports, and positive family history for three generations. In order to unveil the molecular genetic consequences underlying the disease phenotype, we performed next-generation sequencing with a customized and designed panel of genes reported to be associated with hereditary CRC. The variant identified by next-generation sequencing has been validated by Sanger sequencing. A heterozygous novel insertion [c.3992_3993insA; p.Thr1332Asnfs*10] in exon 16 of APC gene has been identified. This novel insertion is cosegregated well with the FAP phenotype among all the affected members of this family. This mutation causes a frameshift by the formation of a premature stop codon which finally results in the formation of a truncated APC protein of 1,342 amino acids instead of the wild type APC protein of 2,843 amino acids. Hence, this is a loss-of-function mutation. This mutation was not found in unaffected family members or in normal control individuals. Our present study emphasizes the importance of a novel approach of the gene panel-based high-throughput sequencing technology for easy and rapid screening for patients with FAP or CRC which will help the clinician for follow-up and management.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 065983818

Download citation: RISBibTeXText

PMID: 30523670

DOI: 10.1002/mgg3.505


Related references

Clinical management of adenomatous polyposis in patients with hereditary non-polyposis colorectal cancer and familial adenomatous polyposis. Zhonghua Yi Xue Za Zhi 86(8): 526-529, 2006

Mutation analysis of the adenomatous polyposis coli (APC) gene in northwest Spanish patients with familial adenomatous polyposis (FAP) and sporadic colorectal cancer. Human Mutation 18(4): 355, 2001

A novel pathogenic large germline deletion in adenomatous polyposis coli gene in a Chinese family with familial adenomatous polyposis. Oncotarget 7(31): 50392-50400, 2016

Novel germline mutations in the adenomatous polyposis coli gene in Polish families with familial adenomatous polyposis. Journal of Medical Genetics 41(1): E11, 2004

Germline mutation of adenomatous polyposis coli gene in Chinese patients with familial adenomatous polyposis. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 25(2): 199-202, 2008

Molecular diagnosis of familial adenomatous polyposis (FAP): Genotyping of adenomatous polyposis coli (APC) alleles by MALDI-TOF mass spectrometry. Clinical Biochemistry 35(2): 87-92, 2002

An AT-rich region in the adenomatous polyposis coli APC gene may cause misinterpretation of Familial Adenomatous Polyposis molecular screening. 2012

Germ line mutations of adenomatous of adenomatous polyposis coli apc gene in a series of french propositi for familial adenomatous polyposis. Gastroenterology 102(4 Part 2): A384, 1992

A novel mutation of the APC (adenomatous polyposis coli) gene in a familial adenomatous polyposis (FAP) patient and presymptomatic diagnosis using PCR. Human Molecular Genetics 2(5): 597, 1993

Molecular analysis of genes responsible for familial adenomatous polyposis and hereditary non polyposis colorectal cancer. Italian Journal of Biochemistry (English Edition) 46(1): 37-38, 1997

Gene Mutations in and Physiopathology of Familial Adenomatous Polyposis and Hereditary Non-Polyposis Colorectal Cancer. Nihon Naika Gakkai Zasshi 96(2): 207-212, 2007

Gene mutations in and physiopathology of familial adenomatous polyposis and hereditary non-polyposis colorectal cancer. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 96(2): 207-212, 2007

Economic evaluation of the familial cancer programme in Western Australia: predictive genetic testing for familial adenomatous polyposis and hereditary non-polyposis colorectal carcinoma. Community Genetics 9(2): 98-106, 2006

Synonymous mutation adenomatous polyposis coliΔ486s affects exon splicing and may predispose patients to adenomatous polyposis coli/mutY DNA glycosylase mutation‑negative familial adenomatous polyposis. Molecular Medicine Reports 18(6): 4931-4939, 2018

Genetic changes of both p53 alleles associated with the conversion from colorectal adenoma to early carcinoma in familial adenomatous polyposis and non-familial adenomatous polyposis patients. Cancer Research 52(14): 3965-3971, 1992